Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115226 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Hatice Bolek und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ankara University School of Medicine, Department of Medical Oncology, Ankara, Turkey; Ankara University Cancer Institute, Ankara, Turkey. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Lutetium, Taxoids, Heterocyclic Compounds, 1-Ring. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Ankara University School of Medicine, Department of Medical Oncology, Ankara, Turkey; Ankara University Cancer Institute, Ankara, Turkey.
- Bilkent City Hospital, Department of Medical Oncology, Ankara, Turkey.
- 12 de Octubre University Hospital, Department of Medical Oncology, Madrid, Spain.
- Izmir University of Economics, Medical Point Hospital, Izmir, Turkey.
- Gaziantep University School of Medicine, Department of Medical Oncology, Gaziantep, Turkey.
- Koc University Medical Faculty, Department of Medical Oncology, Istanbul, Turkey.
Förderung
- Gilead Sciences
Zitieren
APA
Bolek, H., Yazgan, S. C., Ceylan, F., Esteban-Villarrubia, J., Arslan, C., Kuş, T., Tural, D., Sendur, M. A. N., Kucuk, N. O., Çıngı Özdemir, E., Castro, E., Yekedüz, E., & Ürün, Y. (2025). Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115226
Vancouver
Bolek H, Yazgan SC, Ceylan F, Esteban-Villarrubia J, Arslan C, Kuş T, et al. Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS). European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115226
BibTeX
@article{Bolek2025,
author = {Bolek, Hatice and Yazgan, Satı Coskun and Ceylan, Furkan and Esteban-Villarrubia, Jorge and Arslan, Cagatay and Kuş, Tülay and Tural, Deniz and Sendur, Mehmet Ali Nahit and Kucuk, Nuriye Ozlem and Çıngı Özdemir, Elif and Castro, Elena and Yekedüz, Emre and Ürün, Yüksel},
title = {Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115226}
}
EUVIMED